Javier Angulo Frutos;Serafin Valverde Lopez;Antonio Romero Garrido;Guillermo Gimenez Gallego;Rosa Maria Lozano Puerto;Inigo Saenz de Tejada Morgan;Pedro Cuevas Sánchez
发明人:
Pedro Cuevas Sánchez,Guillermo Gimenez Gallego,Inigo Saenz de Tejada Morgan,Javier Angulo Frutos,Rosa Maria Lozano Puerto,Antonio Romero Garrido,Serafin Valverde Lopez
申请号：
US11839525
公开号：
US08541467B2
申请日:
2007.08.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention refers to the use of the compound of Formula (I′) or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of hematological dyscrasias, including myelodisplastic syndromes (MDSs) and for improving the efficacy of chemotherapy, radiation therapy and/or cancer immunotherapy. In addition, it relates to the use of a compound of formula (I″) for the treatment and/or prophylaxis of cancer of an organ.
